Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

VasoNova Inc.

Division of Teleflex Inc.
www.vasonova.com

Latest From VasoNova Inc.

RCT Eyes New Device Strategy

Medical device VCs don’t take to change easily, at least not when they’re asked to alter how they invest. But the BioVentures arm of Research Corporation Technologies is exploring a new avenue for early stage device investing: asset financing.

Medical Device United States

Vascular Access Technologies Inc.

Central venous access continues to be linked to an abnormally high risk of serious and life-threatening complications. Unintended damage to major organs results from the “blind” placement of a hollow needle through the patient’s skin and into the target vein. Vascular Access Technologies Inc. hopes to reduce complications with SAFECVAD, a novel steerable catheter that uses the femoral vein as its point of entry. It is observed under fluoroscopy as it follows a simple guided path to the jugular or subclavian vein, where it makes a visible “inside-out” exit at the exact desired location for central line catheter placement.

Medical Device

Departure, Delays Signal Tough Times For Device Investors

Medical device investment - both in dollars and number of deals - are the lowest they've been in years. But another point of worry comes when venture capital firms begin shrinking not just their portfolios but their device teams as they lose interest in an area.

Deals Shaping the Medical Industry (03/2011)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions.
See All

Company Information

  • Industry
  • Medical Devices
    • Diagnostic Imaging Equipment & Supplies
      • Ultrasound
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Teleflex Inc.
  • Senior Management
  • Paul Molloy, CEO
    Rosa Liu, VP, Fin.
    Steve Hanlon, VP, R&D
  • Contact Info
  • VasoNova Inc.
    Phone: (650) 388-5600
    155 Jefferson Dr.
    Menlo Park, CA 94025
    USA
UsernamePublicRestriction

Register